Base de dados : MEDLINE
Pesquisa : E01.370.225.124.810 [Categoria DeCS]
Referências encontradas : 6050 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 605 ir para página                         

  1 / 6050 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29231657
[Au] Autor:Myren-Svelstad S; Halgunset J
[Ti] Título:Urin har vært brukt til så mangt..
[So] Source:Tidsskr Nor Laegeforen;137(23-24), 2017 12 12.
[Is] ISSN:0807-7096
[Cp] País de publicação:Norway
[La] Idioma:nor
[Mh] Termos MeSH primário: Urina
[Mh] Termos MeSH secundário: Administração Oral
Administração Tópica
História do Século XVIII
História do Século XIX
História do Século XX
Seres Humanos
Mitologia
Urinálise/história
[Pt] Tipo de publicação:HISTORICAL ARTICLE; JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171213
[St] Status:MEDLINE
[do] DOI:10.4045/tidsskr.17.0323


  2 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29328893
[Au] Autor:Simon JF; Nanavati A
[Ad] Endereço:Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH, USA. simonj2@ccf.org.
[Ti] Título:Quality in urine microscopy: The eyes of the beholder.
[So] Source:Cleve Clin J Med;85(1):22-24, 2018 01.
[Is] ISSN:1939-2869
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Microscopia
Urinálise
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:EDITORIAL; COMMENT
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180305
[Lr] Data última revisão:
180305
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180113
[St] Status:MEDLINE
[do] DOI:10.3949/ccjm.85a.17085


  3 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29450506
[Au] Autor:Abbasi J
[Ti] Título:Urine Test for Tuberculosis in Development.
[So] Source:JAMA;319(6):539, 2018 Feb 13.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Lipopolissacarídeos/urina
Tuberculose/diagnóstico
[Mh] Termos MeSH secundário: Biomarcadores/urina
Seres Humanos
Nanotecnologia
Sensibilidade e Especificidade
Tuberculose/urina
Urinálise
[Pt] Tipo de publicação:NEWS
[Nm] Nome de substância:
0 (Biomarkers); 0 (Lipopolysaccharides); 0 (lipoarabinomannan)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180217
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2018.0241


  4 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27773451
[Au] Autor:Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
[Ad] Endereço:Division of Cardiology, Department of Medicine, New York Presbyterian Hospital, Columbia University, New York, New York.
[Ti] Título:Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
[So] Source:J Heart Lung Transplant;36(1):59-63, 2017 Jan.
[Is] ISSN:1557-3117
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Serum lactate dehydrogenase (LDH) is the standard measure for detection of hemolysis and thus surveillance for device thrombosis in patients on continuous-flow left ventricular assist device (CF-LVAD) support. Significant hemolysis has been defined as LDH ≥600 IU/L. However, LDH testing requires phlebotomy, precluding frequent home monitoring. Simple dipstick urinalysis (UA) for urine hemoglobin (U-Hb) overcomes this limitation. This study correlated U-Hb and LDH levels and evaluated the performance of UA for detection of significant hemolysis in patients with CF-LVADs. METHODS: U-Hb and LDH were measured concurrently 956 times in 221 patients with CF-LVADs. Statistics were computed to determine accuracy of UA in detecting LDH ≥600 IU/L, with a positive result being any detected U-Hb. All analyses were performed with and without excluding for 1) conditions associated with tissue damage, which are known to increase LDH, and 2) suspected or confirmed urinary tract infections or hematuria, which are known to cause hemoglobinuria for reasons other than hemolysis. RESULTS: Mean LDH for absent/mild/severe U-Hb was 360 IU/L/467 IU/L IU/L/777 IU/L without exclusions, 354 IU/L/444 IU/L IU/L/651 IU/L after excluding non-hemolytic LDH elevations, 370 IU/L/513 IU/L IU/L/1,357 IU/L after excluding urinary tract infections and hematuria, and 367 IU/L/470 IU/L IU/L/1,217 IU/L when both exclusions applied (all p < 0.001). Absent U-Hb had a negative predictive value for LDH ≥600 IU/L of >90% for all analyses. CONCLUSIONS: Serum LDH is significantly associated with U-Hb levels. Absence of U-Hb appears to efficiently exclude significant hemolysis in patients with CF-LVADs. Because it can be performed by patients at home, hemoglobinuria monitoring may enable more intense surveillance and earlier diagnosis of device thrombosis.
[Mh] Termos MeSH primário: Insuficiência Cardíaca/terapia
Coração Auxiliar/efeitos adversos
Hemoglobinas/metabolismo
Hemólise/fisiologia
Trombose/urina
[Mh] Termos MeSH secundário: Biomarcadores/sangue
Biomarcadores/urina
Falha de Equipamento
Feminino
Insuficiência Cardíaca/mortalidade
Insuficiência Cardíaca/urina
Seres Humanos
Incidência
Estimativa de Kaplan-Meier
L-Lactato Desidrogenase/sangue
Masculino
Meia-Idade
New York/epidemiologia
Reprodutibilidade dos Testes
Estudos Retrospectivos
Fatores de Risco
Taxa de Sobrevida/tendências
Trombose/diagnóstico
Trombose/etiologia
Urinálise
Urofolitropina
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Biomarkers); 0 (Hemoglobins); 0 (Urofollitropin); EC 1.1.1.27 (L-Lactate Dehydrogenase)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  5 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390478
[Au] Autor:Mizuno S; Wakui M; Machida Y; Hosoe N; Hisamatsu T; Ishida T; Kameyama K; Naganuma M; Kanai T
[Ad] Endereço:Division of Gastroenterology and Hepatology, Department of Internal Medicine.
[Ti] Título:Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients: A case report.
[So] Source:Medicine (Baltimore);96(51):e9237, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Mesenteric panniculitis (MP) is a rare disease with abdominal and systemic symptoms and is characterized by nonspecific inflammation, fat necrosis, and fibrosis in mesenteric fat. Active inflammatory responses may increase levels of prostaglandin E-major urinary metabolite (PGE-MUM), which was reported to reflect the disease activity of ulcerative colitis and chronic fibrosing interstitial pneumonia. We recently experienced a case with elevated PGE-MUM at the time of diagnosis of MP and we investigated the potential of PGE-MUM as a biomarker. PATIENT CONCERN: In this report we described 2 active mesenteric panniculitis patients with high PGE-MUM levels. DIAGNOSES: Mesenteric panniculitis INTERVENTIONS:: Both MP patients were measured the levels of PGE-MUM. OUTCOMES: Both MP patients exhibited high levels of PGE-MUM before treatment. In one, the levels were sensitively correlated with clinical symptoms and serological markers on steroids. LESSONS: The study observations suggest the potential of PGE-MUM to reflect the disease activity of MP. To verify its use, more findings based on clinical studies should be accumulated.
[Mh] Termos MeSH primário: Corticosteroides/uso terapêutico
Paniculite Peritoneal/tratamento farmacológico
Paniculite Peritoneal/metabolismo
Prostaglandinas E/metabolismo
[Mh] Termos MeSH secundário: Idoso
Biomarcadores/metabolismo
Feminino
Seguimentos
Seres Humanos
Masculino
Meia-Idade
Paniculite Peritoneal/urina
Medição de Risco
Índice de Gravidade de Doença
Resultado do Tratamento
Urinálise
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Adrenal Cortex Hormones); 0 (Biomarkers); 0 (Prostaglandins E)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009237


  6 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27776634
[Au] Autor:He H; Zhou Z; Dong C; Wang X; Yu QW; Lei Y; Luo L; Feng Y
[Ad] Endereço:Department of Chemistry, Shanghai University, Shanghai 200444, PR China; Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), Department of Chemistry, Wuhan University, Wuhan 430072, PR China. Electronic address: hbhe2006@shu.edu.cn.
[Ti] Título:Facile synthesis of a boronate affinity sorbent from mesoporous nanomagnetic polyhedral oligomeric silsesquioxanes composite and its application for enrichment of catecholamines in human urine.
[So] Source:Anal Chim Acta;944:1-13, 2016 11 09.
[Is] ISSN:1873-4324
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:A boronate-decorated nanomagnetic organic-inorganic hybrid material was facilely synthesized by utilizing the nanomagnetic polyhedral oligomeric silsesquioxanes (POSS) composite (Fe O @POSS) as the base platform. A simple copolymerization occurred between 3-acrylamidophenylboronic acid (AAPBA) and the residual end vinyl groups supplied by the substrate. Here the special emphasis was placed on the octavinyl POSS, which not only acted as the building blocks for a hybrid architecture but also facilitated the process of grafting boronate groups onto the surface of POSS based nanomagnetic composite (Fe O @POSS). The successful immobilization of affinity ligand-AAPBA on the Fe O @POSS was confirmed by Fourier transform infrared (FT-IR), elemental analysis, inductively coupled plasma atomic emission spectrometer (ICP-AES), field emission scanning electron microscope. A magnetic solid-phase extraction (MSPE) for cis-diols enrichment was developed using the as-prepared Fe O @POSS-AAPBA material as an affinity sorbent and three catecholamines (CAs), namely noradrenaline, epinephrine and isoprenaline, as model analytes. Under the optimal extraction conditions, sensitive and simultaneous analysis of three CAs from the urine sample was achieved by high-performance liquid chromatography with UV detection (HPLC-UV). The limits of detection (LOD, S/N = 3) and the limits of quantitation (LOQ, S/N = 10) for the target analytes were 0.81-1.32 ng mL and 2.70-4.40 ng mL , respectively. Also good recoveries (85.5-101.7%) and repeatability (RSD≤10.1%) were obtained by this method. This work not only showed a facility for the utilization of Fe O @POSS as a substrate for constructing a boronate functionalized nanomagnetic sorbent, but also demonstrated the capability of the derived material for recognition of trace amount of cis-diols biomolecules presented in complicated biological matrices.
[Mh] Termos MeSH primário: Ácidos Borônicos/química
Catecolaminas/urina
Nanopartículas de Magnetita/química
Compostos de Organossilício/química
Compostos de Organossilício/síntese química
Polimerização
Urinálise/métodos
[Mh] Termos MeSH secundário: Adsorção
Catecolaminas/química
Técnicas de Química Sintética
Seres Humanos
Concentração de Íons de Hidrogênio
Porosidade
Solventes/química
Fatores de Tempo
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (3-acrylamidophenylboronic acid); 0 (Boronic Acids); 0 (Catecholamines); 0 (Magnetite Nanoparticles); 0 (Organosilicon Compounds); 0 (Solvents)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180116
[Lr] Data última revisão:
180116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE


  7 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28468961
[Au] Autor:Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
[Ad] Endereço:Division of Nephrology and Hypertension, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
[Ti] Título:Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
[So] Source:Am J Physiol Renal Physiol;313(2):F487-F494, 2017 Aug 01.
[Is] ISSN:1522-1466
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The pathways implicated in diabetic kidney disease (DKD) are largely derived from animal models. To examine if alterations in renin-angiotensin system (RAS) in humans are concordant with those in rodent models, we measured concentration of angiotensinogen (AOG), cathepsin D (CTSD), angiotensin-converting enzyme (ACE), and ACE2 and enzymatic activities of ACE, ACE2, and aminopeptidase-A in FVB mice 13-20 wk after treatment with streptozotocin ( = 9) or vehicle ( = 15) and people with long-standing type 1 diabetes, with ( = 37) or without ( = 81) DKD. In streptozotocin-treated mice, urine AOG and CTSD were 10.4- and 3.0-fold higher than in controls, respectively ( < 0.001). Enzymatic activities of ACE, ACE2, and APA were 6.2-, 3.2-, and 18.8-fold higher, respectively, in diabetic animals ( < 0.001). Angiotensin II was 2.4-fold higher in diabetic animals ( 0.017). Compared with people without DKD, those with DKD had higher urine AOG (170 vs. 15 µg/g) and CTSD (147 vs. 31 µg/g). In people with DKD, urine ACE concentration was 1.8-fold higher (1.4 vs. 0.8 µg/g in those without DKD), while its enzymatic activity was 0.6-fold lower (1.0 vs. 1.6 × 10 RFU/g in those without DKD). Lower ACE activity, but not ACE protein concentration, was associated with ACE inhibitor (ACEI) treatment. After adjustment for clinical covariates, AOG, CTSD, ACE concentration, and ACE activity remained associated with DKD. In conclusion, in mice with streptozotocin-induced diabetes and in humans with DKD, urine concentrations and enzymatic activities of several RAS components are concordantly increased, consistent with enhanced RAS activity and greater angiotensin II formation. ACEI use was associated with a specific reduction in urine ACE activity, not ACE protein concentration, suggesting that it may be a marker of exposure to this widely-used therapy.
[Mh] Termos MeSH primário: Diabetes Mellitus Experimental/urina
Diabetes Mellitus Tipo 1/urina
Nefropatias Diabéticas/urina
Enzimas/urina
Insuficiência Renal Crônica/urina
Sistema Renina-Angiotensina
[Mh] Termos MeSH secundário: Adulto
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico
Animais
Biomarcadores/urina
Diabetes Mellitus Experimental/induzido quimicamente
Diabetes Mellitus Experimental/diagnóstico
Diabetes Mellitus Tipo 1/complicações
Diabetes Mellitus Tipo 1/diagnóstico
Nefropatias Diabéticas/diagnóstico
Nefropatias Diabéticas/etiologia
Feminino
Seres Humanos
Masculino
Camundongos
Meia-Idade
Valor Preditivo dos Testes
Insuficiência Renal Crônica/diagnóstico
Insuficiência Renal Crônica/etiologia
Sistema Renina-Angiotensina/efeitos dos fármacos
Regulação para Cima
Urinálise
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Angiotensin-Converting Enzyme Inhibitors); 0 (Biomarkers); 0 (Enzymes)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:171212
[Lr] Data última revisão:
171212
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170505
[St] Status:MEDLINE
[do] DOI:10.1152/ajprenal.00074.2017


  8 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29028822
[Au] Autor:Yuan M; Breitkopf SB; Asara JM
[Ad] Endereço:Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
[Ti] Título:Serial-omics characterization of equine urine.
[So] Source:PLoS One;12(10):e0186258, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Horse urine is easily collected and contains molecules readily measurable using mass spectrometry that can be used as biomarkers representative of health, disease or drug tampering. This study aimed at analyzing microliter levels of horse urine to purify, identify and quantify proteins, polar metabolites and non-polar lipids. Urine from a healthy 12 year old quarter horse mare on a diet of grass hay and vitamin/mineral supplements with limited pasture access was collected for serial-omics characterization. The urine was treated with methyl tert-butyl ether (MTBE) and methanol to partition into three distinct layers for protein, non-polar lipid and polar metabolite content from a single liquid-liquid extraction and was repeated two times. Each layer was analyzed by high performance liquid chromatography-high resolution tandem mass spectrometry (LC-MS/MS) to obtain protein sequence and relative protein levels as well as identify and quantify small polar metabolites and lipids. The results show 46 urine proteins, many related to normal kidney function, structural and circulatory proteins as well as 474 small polar metabolites but only 10 lipid molecules. Metabolites were mostly related to urea cycle and ammonia recycling as well as amino acid related pathways, plant diet specific molecules, etc. The few lipids represented triglycerides and phospholipids. These data show a complete mass spectrometry based-omics characterization of equine urine from a single 333 µL mid-stream urine aliquot. These omics data help serve as a baseline for healthy mare urine composition and the analyses can be used to monitor disease progression, health status, monitor drug use, etc.
[Mh] Termos MeSH primário: Metabolômica/métodos
Urinálise
[Mh] Termos MeSH secundário: Animais
Cavalos
Lipídeos/urina
Fatores de Tempo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Lipids)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171101
[Lr] Data última revisão:
171101
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171014
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0186258


  9 / 6050 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28973230
[Au] Autor:Harel Z; Simel DL; Wald R
[Ad] Endereço:Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
[Ti] Título:Urinalysis in the Evaluation of Proliferative Glomerulonephritis.
[So] Source:JAMA;318(13):1276-1277, 2017 Oct 03.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Glomerulonefrite/diagnóstico
Hematúria/etiologia
Urinálise
[Mh] Termos MeSH secundário: Creatinina/sangue
Diagnóstico Diferencial
Feminino
Glomerulonefrite/complicações
Seres Humanos
Meia-Idade
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
AYI8EX34EU (Creatinine)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171023
[Lr] Data última revisão:
171023
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171004
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.14482


  10 / 6050 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28938419
[Au] Autor:Kolby N; Busch AS; Aksglaede L; Sørensen K; Petersen JH; Andersson AM; Juul A
[Ad] Endereço:Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark.
[Ti] Título:Nocturnal Urinary Excretion of FSH and LH in Children and Adolescents With Normal and Early Puberty.
[So] Source:J Clin Endocrinol Metab;102(10):3830-3838, 2017 Oct 01.
[Is] ISSN:1945-7197
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Context: Clinical use of single serum gonadotropin measurements in children is limited by the pulsatile secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). However, first morning voided (FMV) urine may integrate the fluctuating gonadotropin serum levels. Objective: We aimed to evaluate urinary and serum gonadotropin levels according to age, sex, and pubertal stage in healthy children and to assess the clinical use of FMV urinary gonadotropins in children with disordered puberty. Design: Cross-sectional part of the COPENHAGEN Puberty Study and longitudinal study of patients. Setting: Population-based and outpatient clinic. Patients or Other Participants: Eight hundred forty-three healthy children from the COPENHAGEN Puberty Study and 25 girls evaluated for central precocious puberty (CPP). Main Outcome Measures: Clinical pubertal staging, including serum and urinary gonadotropin levels. Results: Urinary gonadotropins increased with advancing age and pubertal development and were detectable in FMV urine before physical signs of puberty. FMV urinary LH correlated strongly with basal (r = 0.871, P < 0.001) and gonadotropin-releasing hormone (GnRH)-stimulated serum LH (r = 0.82, P < 0.001). Urinary LH was superior to urinary FSH in differentiating the pubertal stage. Receiver operating curve analysis revealed that a cut-off standard deviation (SD) score of 2 for urinary LH (IU/L) gave a sensitivity of 75% and a specificity of 92% in predicting a positive GnRH stimulation test (LHmax > 5 IU/L). Urinary concentrations of LH decreased after 3 months of GnRH treatment to levels below +2 SDs. Conclusions: Urinary gonadotropin levels increased before the onset of puberty and were elevated in girls with CPP. We suggest urinary LH as an alternative noninvasive method to improve diagnosing and therapeutic management of children with disordered puberty.
[Mh] Termos MeSH primário: Ritmo Circadiano
Hormônio Foliculoestimulante/urina
Hormônio Luteinizante/urina
Puberdade Precoce/diagnóstico
Puberdade Precoce/urina
Puberdade/urina
Urinálise/métodos
[Mh] Termos MeSH secundário: Adolescente
Criança
Estudos Transversais
Feminino
Hormônio Foliculoestimulante/sangue
Seres Humanos
Estudos Longitudinais
Hormônio Luteinizante/sangue
Masculino
Puberdade/sangue
Puberdade Precoce/sangue
Sensibilidade e Especificidade
Adulto Jovem
[Pt] Tipo de publicação:CLINICAL TRIAL; JOURNAL ARTICLE
[Nm] Nome de substância:
9002-67-9 (Luteinizing Hormone); 9002-68-0 (Follicle Stimulating Hormone)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171031
[Lr] Data última revisão:
171031
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170923
[St] Status:MEDLINE
[do] DOI:10.1210/jc.2017-01192



página 1 de 605 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde